Robert W. Hesslein Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

Robert W. Hesslein is EVP, CLO and Secretary of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,002 shares of ALNY, which is worth approximately $2.16 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 757 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8K

10.45% 3M change

n/a 12M change

Total Value Held $2.16 Million

Robert W. Hesslein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 03 2025	BUY Grant, award, or other acquisition	-	757 Added 8.64%	8,002 Common Stock
Oct 01 2024	BUY Grant, award, or other acquisition	-	7,245 Added 50.0%	7,245 Common Stock

Also insider at

VYGR

Voyager Therapeutics, Inc. Healthcare

Senior VP & General Counsel

RWH